Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?

od Hauschild, A.
Wydane 2009

Selective effect of pH on the production of exocellular protein by Clostridium perfringens type D.

od Hauschild, A H
Wydane 1966

Peptides for toxinogenesis of Clostridium perfringens type D.

od Hauschild, A H
Wydane 1965

Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas.

od Hauschild, A., Sterry, W.
Wydane 1989

Enumeration of Food-Borne Clostridium perfringens in Egg Yolk-Free Tryptose-Sulfite-Cycloserine Agar

od Hauschild, A. H. W., Hilsheimer, R.
Wydane 1974

Evaluation and Modifications of Media for Enumeration of Clostridium perfringens

od Hauschild, A. H. W., Hilsheimer, R.
Wydane 1974

Food-borne botulism in Canada, 1971-84

od Hauschild, A.H.W., Gauvreau, L.
Wydane 1985

Infant botulism.

od Hauschild, A. H., Bowmer, E. J., Gauvreau, L.
Wydane 1978

Enumeration of Fecal Clostridium perfringens Spores in Egg Yolk-Free Tryptose-Sulfite-Cycloserine Agar

od Hauschild, A. H. W., Hilsheimer, R., Griffith, D. W.
Wydane 1974

Clostridium perfringens Type A Infection of Ligated Intestinal Loops in Lambs

od Hauschild, A. H. W., Niilo, L., Dorward, W. J.
Wydane 1968

Infant botulism in Canada.

od McCurdy, D. M., Krishnan, C., Hauschild, A. H.
Wydane 1981

Preparation of (14)C-labeled Tuberculin Purified Protein Derivative

od Landi, S., Held, H. R., Hauschild, A. H. W., Hilsheimer, R.
Wydane 1967

Thalidomide therapy of established collagen-induced arthritis (CIA) not accompanied by an evident Th2 shift

od HAUSCHILD, A, KROEGER, H, MITCHISON, N A, UGRINOVIC, S, ZWINGENBERGER, K
Wydane 1997

Adsorption of tuberculin PPD to glass and plastic surfaces

od Landi, S., Held, H. R., Hauschild, A. H. W., Hilsheimer, R.
Wydane 1966

Epidemiology of invasive cutaneous melanoma

od MacKie, R. M., Hauschild, A., Eggermont, A. M. M.
Wydane 2009

Staging of cutaneous melanoma

od Mohr, P., Eggermont, A. M. M., Hauschild, A., Buzaid, A.
Wydane 2009

Two different approaches for pharmacokinetic modeling of exhaled drug concentrations

od Kreuer, S., Hauschild, A., Fink, T., Baumbach, J. I., Maddula, S., Volk, Th.
Wydane 2014

Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM

od Egberts, F, Hartje, C, Schafmayer, C, Kaehler, KC, von Schönfels, W, Hauschild, A, Becker, T, Egberts, JH
Wydane 2011

Surgery and radiotherapy in the treatment of cutaneous melanoma

od Testori, A., Rutkowski, P., Marsden, J., Bastholt, L., Chiarion-Sileni, V., Hauschild, A., Eggermont, A. M. M.
Wydane 2009

Biomarkers in melanoma

od Gogas, H., Eggermont, A. M. M., Hauschild, A., Hersey, P., Mohr, P., Schadendorf, D., Spatz, A., Dummer, R.
Wydane 2009